Immigrants have higher risks for some adverse obstetric outcomes. Furthermore, refugees are reported to be the most vulnerable group. This study compared obstetric outcomes between immigrant women originating from conflict-zone countries and ethnic Norwegians who gave birth in a low-risk setting. This was a population-based study linking the Medical Birth Registry of Norway to Statistics Norway. The study included the first registered birth during the study period of women from Somalia (n = 278), Iraq (n = 166), Afghanistan (n = 71), and Kosovo (n = 67) and ethnic Norwegians (n = 6826) at Baerum Hospital from 2006–2010. Background characteristics and obstetric outcomes of each immigrant group were compared with ethnic Norwegians with respect to proportions and risks calculated by logistic regression models. In total, 7408 women and their births were analyzed. Women from Somalia were most at risk for adverse obstetric outcomes. Compared with ethnic Norwegians, they had increased odds ratios (OR) for emergency cesarean section (OR 1.81, CI 1.17–2.80), postterm birth (OR 1.93, CI 1.29–2.90), meconium-stained liquor (OR 2.39, CI 1.76–3.25), and having a small-for-gestational-age infant (OR 3.97, CI 2.73–5.77). They had a reduced OR for having epidural analgesia (OR 0.40, CI 0.28–0.56) and a large-for-gestational-age infant (OR 0.32, CI 0.16–0.64). Women from Iraq and Afghanistan had increased risk of having a small-for-gestational-age infant with OR of 2.21 (CI 1.36–3.60) and 2.77 (CI 1.42–5.39), respectively. Iraqi women also had reduced odds ratio of having a large-for-gestational-age infant (OR 0.35, CI 0.15–0.83). Women from Kosovo did not differ from ethnic Norwegians in any of the outcomes we tested. Even in our low-risk maternity ward, women originating from Somalia were at the greatest risk for adverse obstetric outcomes in the compared groups. We could not find the same risk among the other immigrant women, also originating from conflict-zone countries. Several factors may influence these findings, and this study suggests that immigrant women from Somalia need more targeted care during pregnancy and childbirth.

Breastfed infants are dependent on an adequate supply of iodine in human milk for the production of thyroid hormones, necessary for development of the brain. Despite the importance of iodine for infant health, data on Norwegian lactating women are scarce. We measured iodine intake and evaluated iodine status and iodine knowledge among lactating women. From October to December 2018, 133 mother–infant pairs were recruited in a cross-sectional study through two public health care centers in Lillehammer and Gjøvik. Each of the women provided two human milk specimens, which were pooled, and one urine sample for analysis of iodine concentration. We used 24-h dietary recall and food frequency questionnaire (FFQ) to estimate short-term and habitual iodine intake from food and supplements. The median (P25, P75) human milk iodine concentration (HMIC) was 71 (45, 127) µg/L—of which, 66% had HMIC <100 µg/L. The median (P25, P75) urinary iodine concentration (UIC) was 80 µg/L (52, 141). The mean (± SD) 24-h iodine intake and habitual intake was 78 ± 79 µg/day and 75 ± 73 µg/day, respectively. In conclusion, this study confirms inadequate iodine intake and insufficient iodine status among lactating women in the inland area of Norway and medium knowledge awareness about iodine.

Objectives. Our knowledge of the impact of indigenous culture on drug consumption is scarce. Based on the Sámi Health Study, we compare the use of hypnotics among the Sámi and non-Sámi people, livi...

Persistent organic pollutants (POPs) are stable compounds characterized by their resistance to degradation. From the 1960-70's organochlorine pesticides (OCPs), such as DDTs and polychlorinated biphenyls (PCBs) raised concerns regarding health and environmental impacts. This has led to the banning of POPs in the USA and Europe including Norway in 1980 and worldwide under the 2004 Stockholm Convention. The exposure of nursing infants to POPs has been a significant focus, prompting extensive research into the presence of these substances in human breast milk. In this study, we explored the temporal trends of POPs concentrations in breast milk sampled between 2002 and 2021 by comparing the concentration across the mother's year of birth. Two Norwegian cohorts of lactating women were utilized (the HUMIS study and the "Iodine in Early Life"-Study). Concentrations of 15 different POPs, including PCBs, OCPs, and brominated diphenyl ethers (BDEs) were measured in 513 breast milk samples that had been collected over two decades in a subset of first-time mothers. Time trend analysis indicated a steady decrease in concentration levels when adjusted for maternal age. The largest reduction was observed in β-HCH, age-adjusted (-17.1%, 95% CI -18.7, -15.4), followed by ∑₆BDE (-9.1%, 95% CI -10.5, -7.7), ∑₆PCBs (-7.1%, 95% CI -7.7, -6.5), and ∑₂DDTs (-7.0%, 95% CI -8.0, -6.0). In contrast, an increasing trend was noted in the median concentrations of β-HCH, ∑₂DDTs, and ∑₆BDE in the mothers born in 1990-1994 to 1995-2002. Our study demonstrates a decline of most POPs in breast milk, likely attributed to international regulatory efforts like the Stockholm Convention. Notably, an increase in the 95th percentile concentrations of β-HCH, ∑₂DDTs, and ∑₆BDEs was noted in mothers born in 1990-1994 compared to those born in 1995-2002 suggests demographic shifts that may influence exposure levels. Further research is needed to explore and understand the underlying factors for the rise in median concentrations of ∑₆BDEs.